Investment funds, asset management, and benchmarks

This subtopic contains the following documents:

Investment funds and asset management

Practice Notes

•
EU AIFMD—essentials—this Practice Note explores key elements of the Alternative Investment Fund Managers Directive (Directive 2011/61/EU) (AIFMD), including the scope of the AIFMD, exemptions available under the AIFMD, the AIFMD regulatory framework, the AIFMD authorisation process and AIFMD for small alternative investment funds (AIFs), as well as related EU regimes
•
EU AIFMD—one minute guide—this one minute guide provides a condensed summary of the key requirements of the AIFMD, as amended
•
EU AIFMD—the marketing of AIFs, passporting and third country provisions—this Practice Note explores the measures in the AIFMD relating to the rights and regulatory requirements of an EU alternative investment fund manager (AIFM) to market and manage an AIF in the EU and considers the EU-wide passport for cross-border services and marketing to professional clients and national private placement regimes (NPPRs)
•
Key provisions of EU AIFMD—depositaries—this Practice Note considers the role of depositaries under the AIFMD regime. It examines the requirements for a depositary under the AIFMD, the functions of depositaries,

To view the latest version of this document and thousands of others like it, sign-in with LexisNexis or register for a free trial.

TAKE A FREE TRIAL

Latest EU Law News

European Commission adopts delegated act on Master UDI-DI for spectacle products

The European Commission adopted on 12 June 2025 a delegated act amending Regulation (EU) 2017/745, the Medical Devices Regulation (MDR), to introduce the Master UDI-DI solution for spectacle frames, spectacle lenses, and ready-to-wear reading spectacles. This solution, which already covers contact lenses, uses a single identifier, the Master UDI-DI, to represent certain devices with high individualisation, instead of assigning standard unique device identification (UDIs) to each device individually. The delegated act is currently under a scrutiny period and will be published afterwards. Additionally, a Medical Device Coordination Group guidance document is being developed to outline the implementation timelines for the Master UDI-DI concerning spectacle frames, spectacle lenses, and ready-to-wear reading spectacles and provide practical details for manufacturer.s

European Commission publishes 2025 State of the Digital Decade report

The European Commission has published its 2025 State of the Digital Decade report, urging renewed action on digital transformation and technological sovereignty. The report evaluates the EU's progress toward its 2030 digital transformation targets by examining four areas: digital infrastructure, business digitalisation, digital skills, and public service digitalisation. It reveals that while some progress has been made, the rollout of connectivity infrastructure such as fibre and 5G stand-alone networks remains slow. There is an increasing uptake of AI, cloud, and big data by companies, yet more rapid progress is essential. Furthermore, only just over half of Europeans have basic digital skills, and there is a shortage of advanced ICT specialists, a situation worsened by a significant gender imbalance which restricts progress in key sectors like cybersecurity and AI. Although the digitalisation of public services has made headway, a considerable portion of governmental digital infrastructure continues to rely on providers from outside the EU. Persistent challenges such as fragmented markets, complex regulations and strategic dependence call for greater public and private investment, reforms to better integrate the single market, and eased administrative burdens. These measures could potentially boost the EU's gross domestic product by an estimated 1.8% by 2030. Member States are set to review the recommendations and discuss the future course of action, with further assessments scheduled for 2026 to ensure that targets remain in line with the evolving digital landscape and the EU's broader ambitions.

EFPIA issues recommendations to stop chemical safety assessments animal testing

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has issued recommendations on 12 June 2025 on phasing out animal testing for chemical safety assessments. Its latest proposals, based on the '3Rs' principles of Replacement, Reduction, and Refinement, introduce a three-tiered approach that categorises tests according to their current applicability and future potential, thereby outlining a clear pathway for implementation. This roadmap illustrates a broader evolution in scientific strategy, embracing advances in organ-on-chip technology and AI-driven toxicology, as well as encouraging global collaborative efforts to align with emerging regulatory and ethical standards. While recognising challenges such as regulatory fragmentation, data silos, and intellectual property concerns, the strategy relies on transparent engagement and a commitment to harmonising international efforts, striving for a future of safety science that is both innovative and ethical.

EBA publishes final draft technical standards on operational risk

The European Banking Authority (EBA) has published three final draft technical standards for the implementation of the EU Banking Package. They will allow supervisors to monitor institutions’ compliance, in order to promote consistent and enhanced supervision. The EBA is seeking to ensure comprehensive and accurate representation of operational risk in banks' financial statements.